Valuation: Itaconix plc

Market Cap 19.82M 26.38M 23.2M 21.55M 37.18M 2.55B 37.84M 258M 101M 1.25B 99.04M 96.9M 4.32B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 17.24M 22.94M 20.18M 18.75M 32.33M 2.22B 32.91M 224M 87.43M 1.08B 86.13M 84.27M 3.76B EV / Sales 2026 *
1.57x
EV / Sales 2027 * 1.45x
Free-Float
84.16%
Yield 2026 *
-
Yield 2027 * -
1 day+0.50%
1 week-1.83%
Current month+33.10%
1 month+33.10%
3 months+36.80%
6 months+22.10%
Current year+37.43%
1 week 141.48
Extreme 141.4816
174
1 month 107
Extreme 107
174
Current year 97
Extreme 97
174
1 year 97
Extreme 97
174
3 years 92.5
Extreme 92.5
274
5 years 92.5
Extreme 92.5
565
10 years 13
Extreme 13.005
2,000
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Executive Officer 66 11/07/2018
Director of Finance/CFO 43 31/10/2013
Director TitleAgeSince
Director/Board Member 66 11/07/2018
Director/Board Member 62 08/02/2024
Director/Board Member 43 19/07/2022
Date Insider Type Main position Quantity % Market Cap.
05/05/26 Buy

Chairman

3,400 0.0252%
23/04/26 Free

Chief Financial Officer

12,675 0.0940%
23/04/26 Free

Founder

107,888 0.8000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%-1.83%+7.84%-25.57% 26.38M
-1.40%-4.56%-2.00%+39.10% 74.06B
-0.42%-7.95%-12.84%+9.64% 35.89B
+0.19%-2.68%-25.31%-40.11% 30.24B
-0.87%-0.19%+12.54%+32.87% 26.47B
+0.22%+3.22%+19.22%+10.18% 22.46B
+0.16%+4.51%+75.27%-6.93% 19.8B
-1.60%+2.32%-40.19%-39.04% 18.55B
-0.46%-2.13%+48.38%-45.87% 13.79B
+0.15%-3.32%-2.86%-10.80% 13.33B
Average -0.36%+0.72%+8.01%-7.65% 25.46B
Weighted average by Cap. -0.64%-2.73%+3.00%+5.85%

Financials

2026 *2027 *
Net sales 10.98M 14.61M 12.85M 11.94M 20.6M 1.42B 20.96M 143M 55.69M 690M 54.86M 53.68M 2.39B 12M 15.97M 14.05M 13.05M 22.51M 1.55B 22.91M 156M 60.87M 754M 59.96M 58.67M 2.62B
Net income - -
Net Debt -2.58M -3.44M -3.02M -2.81M -4.85M -333M -4.93M -33.59M -13.1M -162M -12.91M -12.63M -563M -2.37M -3.15M -2.77M -2.58M -4.44M -305M -4.52M -30.8M -12.02M -149M -11.84M -11.58M -517M
Logo Itaconix plc
Itaconix plc is an innovator in sustainable plant-based polymers used to decarbonize everyday consumer products. The Company’s principal activities are the development of plant-based polymers, and the production and sale of these materials globally, both directly and through partners as ingredients in product formulations. The Company’s segments include Itaconix Performance Ingredients, SPARX Formulated Solutions, and BIO*Asterix. Itaconix Performance Ingredients develops, produces, and sells proprietary specialty polymers that are used as functional ingredients to meet customer needs in cleaning, beauty and hygiene products. SPARX Formulated Solutions provides technical services and ingredient supplies for formulated products developed for customers based on Performance Ingredients. BIO*Asterix develops, produces, and sells specialty itaconate monomers as plant-based alternatives to acrylates and styrenes in paint, coating, and adhesive applications.
Employees
28
Date Price Change Volume
24/07/26 GBX 147.74 +0.50% 638
23/07/26 GBX 147.00 -1.67% 16,336
22/07/26 GBX 149.50 0.00% 15,581
21/07/26 GBX 149.50 -11.01% 108,873
20/07/26 GBX 168.00 +11.63% 187,664
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.470GBP
Average target price
3.750GBP
Spread / Average Target
+155.10%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. REVO Stock